BioNTech SE (BNTX) Change in Acquisitions & Divestments (2021 - 2022)
BioNTech SE (BNTX) posted Change in Acquisitions & Divestments of -$17.0 million for Q4 2022, up 45.66% on a QoQ basis from -$31.4 million in Q3 2022, and up 23.62% year-over-year from -$13.8 million in Q4 2021.
BioNTech SE (BNTX) has 2 years of Change in Acquisitions & Divestments data on file, last reported at -$17.0 million in Q4 2022.
- In Q4 2022, Change in Acquisitions & Divestments rose 23.62% year-over-year to -$17.0 million; the TTM figure through Dec 2022 stood at -$73.9 million (changed N/A YoY), while the FY2022 annual figure was -$48.8 million, down 118.62% from the prior year.
- Change in Acquisitions & Divestments improved to -$17.0 million in Q4 2022, from -$31.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at -$3.2 million in Q2 2022 and bottomed at -$31.4 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -17.04 Mn |
| Dec 31, 2022 | -17.04 Mn |
| Sep 30, 2022 | -31.36 Mn |
| Sep 30, 2022 | -31.36 Mn |
| Jun 30, 2022 | -3.20 Mn |
| Jun 30, 2022 | -3.20 Mn |
| Dec 31, 2021 | -22.31 Mn |
| Dec 31, 2021 | -22.31 Mn |